Source: China News Network
China News Service, November 11, according to Korea Broadcasting International (KBS): South Korea’s Celltrion Group Chairman Xu Tingzhen said that the new coronavirus antibody therapeutic agent being developed in clinical trials has eliminated the body of patients within 4 to 5 days. New crown virus.
On the 11th, Xu Tingzhen made the above remarks when introducing the interim results of the clinical trial of Celltrion’s new coronavirus antibody therapeutic agent “CT-P59” currently under development.
Xu Tingzhen said that based on the results of the current clinical trials, the therapeutic agent will eliminate the new coronavirus in the patient within 4 to 5 days, eliminating the possibility of the patient developing a severe illness or organ damage.
Celltrion said that Xu Tingzhen introduced the results of a phase 1 clinical trial of the new coronavirus antibody therapeutic agent “CT-P59” that was conducted on mild patients.Return to Sohu to see more
Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.